J. Babcock

Phase I study of a Neisseria meningitidis liposomal vaccine containing purified outer membrane proteins and detoxified lipooligosaccharide.

G. Matyas, C. Alving, B. Brandt, 2012, Vaccine.

Studies of the hyperviscosity syndrome. II. Macroglobulinemia.

M. Mackenzie, J. Babcock, 1975, The Journal of laboratory and clinical medicine.

Evaluation of sex, race, body mass index and pre-vaccination serum progesterone levels and post-vaccination serum anti-anthrax protective immunoglobulin G on injection site adverse events following anthrax vaccine adsorbed (AVA) in the CDC AVA human clinical trial.

W. Keitel, R. Jacobson, G. Poland, 2014, Vaccine.

Rodenticide‐Induced Coagulopathy in a Young Child: A Case of Munchausen Syndrome by Proxy

Melissa S. Murphy, B. Alving, K. Hartman, 1993, The American journal of pediatric hematology/oncology.

Effect of reduced dose schedules and intramuscular injection of anthrax vaccine adsorbed on immunological response and safety profile: a randomized trial.

Sandra K. Martin, W. Keitel, N. Marano, 2014, Vaccine.

Humoral and Cell-Mediated Immune Responses to Alternate Booster Schedules of Anthrax Vaccine Adsorbed in Humans

J. Wrammert, R. Ahmed, W. Keitel, 2016, Clinical and Vaccine Immunology.

Effects of a reduced dose schedule and intramuscular administration of anthrax vaccine adsorbed on immunogenicity and safety at 7 months: a randomized trial.

Sandra K. Martin, M. Mulligan, W. Keitel, 2008, JAMA.

Health-related quality of life in the CDC Anthrax Vaccine Adsorbed Human Clinical Trial.

W. Keitel, J. Tokars, R. Jacobson, 2012, Vaccine.